Market Rank #36 · Evidence Tier A

Ireland
Neuroscience Intelligence

Ireland neuroscience intelligence: 37 indexed trials, 13 institutions, research score 26.21.

⚗
37Indexed trials
↗
10Recruiting
⌂
13Research institutions
◎
26.2Research score

Evidence profile

25Sponsors
12Disease areas
0Institution works
0Institution citations

Model signals

Opportunity 26 · ML priority 26 · Confidence 100 · Evidence 26.2

These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.

Leading disease areas

parkinsons11trials
alzheimers5trials
epilepsy4trials
stroke3trials
other_neurology1trials
schizophrenia1trials
adhd1trials
traumatic_brain_injury1trials
als1trials
autism1trials

Leading indexed sponsors

Merck Sharp & Dohme LLC10trials
AbbVie2trials
University College Dublin2trials
Novo Nordisk A/S2trials
FUJIFILM Toyama Chemical Co., Ltd.1trials
Health Service Executive, Ireland1trials
Amylyx Pharmaceuticals Inc.1trials
Eli Lilly and Company1trials
Massachusetts General Hospital1trials
Heidelberg University1trials